SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGooch & Housego Regulatory News (GHH)

Share Price Information for Gooch & Housego (GHH)

Share Price is delayed by 15 minutes
Get Live Data
992.00    44.00 (4.64%)
Bid:
972.00
Ask:
988.00
Spread: 16.00 (1.646%)
Market Cap: £271.52m
GHH Live PriceLast checked at - London Stock Exchange

Intraday Gooch & Housego Share Chart

Trading Update and Directorate Changes

17 Aug 2022 07:00

RNS Number : 2403W
Gooch & Housego PLC
17 August 2022
 

 

For immediate release

17 August 2022

 

Gooch & Housego PLC

("G&H" or the "Company" or the "Group")

 

Trading Update and Directorate Changes

 

"Further order book momentum, but short-term output constrained"

 

Gooch & Housego PLC (AIM: GHH), the specialist manufacturer of photonic components & systems, provides an update on trading and proposed directorate changes.

 

Strong order book

 

In the second half of the financial year, we have continued to see strong and improving levels of demand for the Group's products and services and the order book has reached another record level. Overall demand is strong across all principal areas of the business, namely industrial lasers, telecoms, A&D and life sciences:

- Continued high demand for industrial lasers, in particular for those used in semiconductor manufacturing where a combination of high market growth and our new products winning market share has led to substantial growth.

- Extended order book visibility has been secured for our Hi-reliability fibre couplers for undersea cables and increasingly for constellation space satellites.

- In the last few months, we have seen a notable increase in A&D orders, both in the US and Europe, where there has been further interest in our upgraded optical imaging system for armoured vehicles following the award of the £4 million Challenger 3 Tank contract announced earlier this year.

- Medical lasers continue to benefit from the return of elective surgery and demand for our medical diagnostics products remains high.

 

As at 31 July 2022 our order book stood at a record £140.6 million (31 July 2021: £97.7 million) a 43.9% increase on the same time last year, or 32.6% at constant currency. This represents an increase on the strong half year order book of 17.3% (31 March 2022: £119.9 million), or 12.6% at constant currency.

 

Current trading and full year outlook

 

G&H has and continues to invest materially to add further productive capacity to meet the demands of a growing order book. Our ability to expand capacity in the second half of the financial year has however been 'gated' by highly competitive labour markets in the UK and US, supply chain shortages, in particular electronic parts from Asia and COVID-related absences. Relatively good progress has been made hiring and training new operators, but this has been partially offset by higher than 'normal' rates of attrition. As such the capacity ramp up is taking longer than expected and longer than similar capacity ramp ups have typically taken in the past.

 

Second half trading levels are expected to be better than the first half of the financial year due to the actions taken to improve recruitment and ameliorate supply chain shortages with higher inventory, but the longer ramp up and the higher level of investment to meet the increased order book mean that adjusted profit before tax is now forecast to be around £3.5 million lower than management's previous expectations.

 

Given the lower levels of profitability now expected for the financial year, management will review intangible asset carrying values and make any required adjustments as part of the year end close.

 

FY2023 Outlook

 

Given the strong order book visibility for FY2023 and the ramp up in capacity that is being delivered by the Group we expect to deliver double-digit volume growth in the coming financial year. Our work to mitigate the effect of input cost inflation through pricing adjustment continues to be successful and we expect this to be ongoing. The growth in revenue is expected to positively drive the Group's EBIT margin in FY2023.

 

Dividend

 

The Board's intention is to maintain a progressive full year dividend per share in the range of 12.4p to 12.7p for FY2022 (FY2021: 12.2p), reflecting the positive longer-term outlook for the Group.

 

Inorganic expansion

 

The Company continues to review options to support the growth of the Group through acquisitions. The Group's robust balance sheet and existing long term debt facilities mean that we are well placed to execute on this element of our strategy.

 

Mark Webster, Chief Executive Officer of Gooch & Housego, commented:

 

"In the second half of the financial year we have continued to see strong and improving levels of overall demand and a record order book across all principal areas of the business. G&H has invested in adding productive capacity to meet increasing demand but has been 'gated' by highly competitive labour markets in the UK and US, supply chain shortages and COVID-related absences.

 

"In addition to the progress that has been made with recruitment and retention we are accelerating the transfer of our higher volume products to our contract manufacturer in Asia in order to add further capacity.

 

"Fundamental demand for our photonic technologies and system capabilities is strong and improving and though the short-term impact of capacity constraints is disappointing we remain confident in the long growth potential of all our target sectors."

 

 

Directorate changes

 

G&H also announces that Mark Webster will be retiring at the end of this financial year and stepping down from his role as CEO of G&H. Mark has served over 10 years at G&H, most recently as CEO for over 8 years, and prior to that as a Non-Executive Director. He has led the Group's transformation and expansion into new market opportunities, especially in the Life Sciences and A&D sectors, and most recently through a challenging international economic backdrop which encompassed the COVID pandemic.

 

The Board is pleased to announce that he will be succeeded as CEO of G&H by Charlie Peppiatt, with effect from 14 September 2022, who until recently was Executive Vice President at TT Electronics PLC, which he joined after they acquired Stadium Group PLC in 2018 where he was CEO. Charlie brings a wealth of experience from his career in global hi-tech businesses supplying into the medical, industrial, aerospace and defence sectors, not only from his time in these roles but also prior to that at Laird PLC, where his roles included VP

Global Operations for Laird Technologies based in China, General Manager for Amesbury Group based in USA and Managing Director with Laird Security Systems in the UK.

 

There will be a period of handover between Mark and Charlie in the latter part of September.

 

Gary Bullard, Chairman of G&H said:

"Mark has led G&H for over 8 years through significant transformation and change. The Group is now a better balanced and professional business with a strong platform for future growth. We wish him well in his retirement and thank him for his service.

 

"I am delighted to welcome Charlie to G&H and believe he is uniquely qualified to lead the Group in exploiting the significant opportunities that are opening up to us and the continued growth of the photonics sector."

 

Charlie Peppiatt said:

"I am thrilled to be joining the global team at G&H and look forward to leading the organisation to accelerate its organic growth and acquisition strategy, deliver improved profitability and set the business on track to create further value for our shareholders."

 

For further information contact:

 

Mark Webster / Chris Jewell 

Gooch & Housego PLC

01460 256440

Mark Court / George Cleary

 

Buchanan

020 7466 5000

Christopher Baird / David Anderson

 

Investec Bank plc

020 7597 5970

 

 

Notes to editors

 

 

1.Gooch & Housego is a photonics technology business headquartered in Ilminster, Somerset, UK with operations in the USA and Europe. A world leader in its field, the company researches, designs, engineers and manufactures advanced photonic systems, components and instrumentation for applications in the Aerospace & Defence, Industrial, Life Sciences and Scientific Research sectors. World leading design, development and manufacturing expertise is offered across a broad range of complementary technologies.

 

2.All financial information included in this announcement is sourced from unaudited management accounts and excludes any specific items. This announcement contains certain forward-looking statements that are based on management's current expectations or beliefs as well as assumptions about future events. These are subject to risk factors associated with, amongst other things, the economic and business circumstances occurring from time to time in the countries and sectors in which G&H operates. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a wide range of variables which could cause actual results, and G&H's plans and objectives, to differ materially from those currently anticipated or implied in the forward-looking statements. Investors should not place undue reliance on any such statements. Nothing in this announcement should be construed as a profit forecast.

 

 

The following information is disclosed pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies.

 

Charles St John Stewart Peppiatt (aged 52 years) holds no current directorships. In the past five years he has held the following directorships or partnerships:

 

 

Dongguan Arlec Electrical Products Co. Limited

Ferrus Power Limited

Fox Industries Limited

Hale End Holdings Limited

Intron Limited

Kingslo Limited

KRP Power Source (UK) Limited

Optek Technology Inc

Stadium Asia Limited

Stadium Electrical Holdings Limited

Stadium Electronics Limited

Stadium IGT Limited

Stadium Power Limited

Stadium United Wireless Limited

Stadium Wireless Devices Limited

Stadium Zirkon UK Limited

STMC Limited

Stontronics Limited

TT Electronics IOT Solutions Limited

TT Electronics Sweden AB

Valuegolden Limited

Ying Si Ke Electrical Products Co. Limited

Zirkon Holdings Limited

 

There is no further information to be disclosed pursuant to Rule 17 or Schedule Two paragraph (g) of the AIM Rules for Companies.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDGPUMGRUPPGRQ
Date   Source Headline
3rd Jun 20267:00 amRNSDirectorate change
2nd Jun 20267:00 amRNSInterim Results
20th May 20267:00 amRNSNotice of Half Year Results
10th Apr 20262:25 pmRNSHolding(s) in Company
9th Apr 20267:00 amRNSHalf Year Trading Update
20th Mar 20263:16 pmRNSHolding(s) in Company
27th Feb 20262:23 pmRNSResult of AGM
27th Feb 20267:00 amRNSAGM Trading Update
2nd Feb 20267:00 amRNSChief Financial Officer appointment date
22nd Jan 20262:26 pmRNSHolding(s) in Company
13th Jan 20264:41 pmRNSHolding(s) in Company
12th Jan 20264:34 pmRNSPDMR notice
12th Jan 20263:30 pmRNSGrant of LTIP awards
9th Jan 20267:00 amRNSPDMR Notice and Issue of Equity
7th Jan 20267:00 amRNSPosting of Annual Report and Notice of AGM
12th Dec 20257:00 amRNSAppointment of Chief Financial Officer
2nd Dec 202511:36 amRNSDirector/PDMR Shareholding
2nd Dec 20257:00 amRNSResults for the year ended 30 September 2025
25th Nov 20257:00 amRNSNotification of Full Year Results
20th Nov 20252:14 pmRNSHolding(s) in Company
4th Nov 20257:07 amRNSDirectorate Update
8th Oct 20257:00 amRNSFurther Issue of Shares and TVR
7th Oct 20257:00 amRNSFull Year Trading Update
1st Oct 20252:15 pmRNSHolding(s) in Company
21st Jul 20257:00 amRNSChief Financial Officer Transition
15th Jul 20255:08 pmRNSHolding(s) in Company
30th Jun 20257:00 amRNSNotification of Major Holdings
23rd Jun 20252:30 pmRNSHolding(s) in Company - Replacement
20th Jun 202512:08 pmRNSHolding(s) in Company
18th Jun 20257:00 amRNSCompletion of Acquisition & Total Voting Rights
3rd Jun 20257:00 amRNSInterim Results
20th May 20257:00 amRNSNotification of Half Year Results
14th May 20257:00 amRNSAcquisition of Global Photonics
9th Apr 20252:16 pmRNSHolding(s) in Company
8th Apr 20257:00 amRNSHalf Year Trading Update
24th Feb 20252:19 pmRNSResult of AGM
24th Feb 20257:00 amRNSAGM Trading Update
7th Jan 20252:58 pmRNSGrant of LTIP Awards
6th Jan 202511:15 amRNSPosting of Annual Report and Notice of AGM
20th Dec 20243:15 pmRNSHolding(s) in Company
3rd Dec 20247:00 amRNSResults for the year ended 30 September 2024
4th Nov 20247:00 amRNSNotification of Full Year Results
30th Oct 20247:00 amRNSAcquisition of Phoenix Optical
28th Oct 20242:35 pmRNSHolding(s) in Company
8th Oct 20247:00 amRNSFull Year Trading Update
26th Sep 202410:31 amRNSDirector/PDMR Shareholding
23rd Aug 202412:52 pmRNSNotification of Major Holdings
16th Aug 20245:46 pmRNSHolding(s) in Company
16th Aug 20244:49 pmRNSHolding(s) in Company
15th Aug 20244:33 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.